ID

23230

Descripción

Phase II Study of Alimta (Pemetrexed) Treatment of Advanced Thymoma and Thymic Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT00198133

Link

https://clinicaltrials.gov/show/NCT00198133

Palabras clave

Versiones (1)
  1. 29/6/17 29/6/17 -
Subido en

29 de junio de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Thymoma NCT00198133

Inglés

Eligibility Thymoma NCT00198133

1 formularios  
  1. StudyEvent: Eligibility
    1. Eligibility Thymoma NCT00198133
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically confirmed invasive, recurrent or metastatic thymoma or thymic carcinoma not amenable to potentially curative therapy by surgery. original biopsy of tumor is sufficient for diagnoses unless otherwise clinically indicated.
Descripción

Thymoma invasive | Thymoma recurrent | Thymoma metastatic | Thymic Carcinoma Curative Surgery Unsuccessful | Thymoma Biopsy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0278846
UMLS CUI [2]
C0278848
UMLS CUI [3,1]
C0040100
UMLS CUI [3,2]
C1522484
UMLS CUI [4,1]
C0205969
UMLS CUI [4,2]
C1511562
UMLS CUI [4,3]
C1272705
UMLS CUI [5,1]
C0040100
UMLS CUI [5,2]
C0005558
patients must have measurable disease with at least one bidimensional measurable lesion. any scans or x-rays used to document measurable disease must be obtained with 6 weeks prior to registration.
Descripción

Measurable lesion 2-Dimensional Quantity | Measurable Disease Scan | Measurable Disease X-ray

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1513041
UMLS CUI [1,2]
C1705052
UMLS CUI [1,3]
C1265611
UMLS CUI [2,1]
C1513041
UMLS CUI [2,2]
C0441633
UMLS CUI [3,1]
C1513041
UMLS CUI [3,2]
C0034571
patients may have had prior chemotherapy for metastatic disease
Descripción

Chemotherapy Neoplasm Metastasis

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C0027627
adequate organ function as defined by: bili </=1.5; calc. crt clr of >/=45; hematologic-granulocytes >/=1500 & plt >/=100k.
Descripción

Organ function | Serum total bilirubin measurement | Ratio Calcium Creatinine clearance | Hematology | Granulocyte count | Platelet Count measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0678852
UMLS CUI [2]
C1278039
UMLS CUI [3,1]
C0456603
UMLS CUI [3,2]
C0006675
UMLS CUI [3,3]
C0812399
UMLS CUI [4]
C0200627
UMLS CUI [5]
C0857490
UMLS CUI [6]
C0032181
patients who are receiving a stable dose of corticosteroids for myasthenia gravis are eligible.
Descripción

Adrenal Cortex Hormones Dose Stable | Myasthenia Gravis

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0001617
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0205360
UMLS CUI [2]
C0026896
ecog performance status of 0 or 1
Descripción

ECOG performance status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1520224
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
acute intercurrent infection or complications
Descripción

Communicable Disease | Complication

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0009450
UMLS CUI [2]
C0009566
pregnancy or lactating patients
Descripción

Pregnancy | Breast Feeding

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
inability to interrupt aspirin or other nonsteroidal anti-inflammatory agents for a 5-day period (8-day period for long-acting agents.
Descripción

Aspirin Discontinue Unable | Non-Steroidal Anti-Inflammatory Agents Discontinue Unable

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0004057
UMLS CUI [1,2]
C1444662
UMLS CUI [1,3]
C1299582
UMLS CUI [2,1]
C0003211
UMLS CUI [2,2]
C1444662
UMLS CUI [2,3]
C1299582
presence of clinically relevant third-space fluid collections that cannot be controlled by a procedure
Descripción

Body Fluid Space Third Uncontrolled

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0005889
UMLS CUI [1,2]
C1883067
UMLS CUI [1,3]
C0205437
UMLS CUI [1,4]
C0205318
Volver a la parte superior de la página

Similar models

Eligibility Thymoma NCT00198133

1 formularios
  1. StudyEvent: Eligibility
    1. Eligibility Thymoma NCT00198133
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Thymoma invasive | Thymoma recurrent | Thymoma metastatic | Thymic Carcinoma Curative Surgery Unsuccessful | Thymoma Biopsy
Item
histologically confirmed invasive, recurrent or metastatic thymoma or thymic carcinoma not amenable to potentially curative therapy by surgery. original biopsy of tumor is sufficient for diagnoses unless otherwise clinically indicated.
boolean
C0278846 (UMLS CUI [1])
C0278848 (UMLS CUI [2])
C0040100 (UMLS CUI [3,1])
C1522484 (UMLS CUI [3,2])
C0205969 (UMLS CUI [4,1])
C1511562 (UMLS CUI [4,2])
C1272705 (UMLS CUI [4,3])
C0040100 (UMLS CUI [5,1])
C0005558 (UMLS CUI [5,2])
Measurable lesion 2-Dimensional Quantity | Measurable Disease Scan | Measurable Disease X-ray
Item
patients must have measurable disease with at least one bidimensional measurable lesion. any scans or x-rays used to document measurable disease must be obtained with 6 weeks prior to registration.
boolean
C1513041 (UMLS CUI [1,1])
C1705052 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
C1513041 (UMLS CUI [2,1])
C0441633 (UMLS CUI [2,2])
C1513041 (UMLS CUI [3,1])
C0034571 (UMLS CUI [3,2])
Chemotherapy Neoplasm Metastasis
Item
patients may have had prior chemotherapy for metastatic disease
boolean
C0392920 (UMLS CUI [1,1])
C0027627 (UMLS CUI [1,2])
Organ function | Serum total bilirubin measurement | Ratio Calcium Creatinine clearance | Hematology | Granulocyte count | Platelet Count measurement
Item
adequate organ function as defined by: bili </=1.5; calc. crt clr of >/=45; hematologic-granulocytes >/=1500 & plt >/=100k.
boolean
C0678852 (UMLS CUI [1])
C1278039 (UMLS CUI [2])
C0456603 (UMLS CUI [3,1])
C0006675 (UMLS CUI [3,2])
C0812399 (UMLS CUI [3,3])
C0200627 (UMLS CUI [4])
C0857490 (UMLS CUI [5])
C0032181 (UMLS CUI [6])
Adrenal Cortex Hormones Dose Stable | Myasthenia Gravis
Item
patients who are receiving a stable dose of corticosteroids for myasthenia gravis are eligible.
boolean
C0001617 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C0026896 (UMLS CUI [2])
ECOG performance status
Item
ecog performance status of 0 or 1
boolean
C1520224 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Communicable Disease | Complication
Item
acute intercurrent infection or complications
boolean
C0009450 (UMLS CUI [1])
C0009566 (UMLS CUI [2])
Pregnancy | Breast Feeding
Item
pregnancy or lactating patients
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Aspirin Discontinue Unable | Non-Steroidal Anti-Inflammatory Agents Discontinue Unable
Item
inability to interrupt aspirin or other nonsteroidal anti-inflammatory agents for a 5-day period (8-day period for long-acting agents.
boolean
C0004057 (UMLS CUI [1,1])
C1444662 (UMLS CUI [1,2])
C1299582 (UMLS CUI [1,3])
C0003211 (UMLS CUI [2,1])
C1444662 (UMLS CUI [2,2])
C1299582 (UMLS CUI [2,3])
Body Fluid Space Third Uncontrolled
Item
presence of clinically relevant third-space fluid collections that cannot be controlled by a procedure
boolean
C0005889 (UMLS CUI [1,1])
C1883067 (UMLS CUI [1,2])
C0205437 (UMLS CUI [1,3])
C0205318 (UMLS CUI [1,4])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial